Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon R Payne

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Epigenomics|November 30, 2011
From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in bloodShannon R Payne
Carcinogenesis|September 10, 2005
Tumor suppressor geneticsShannon R Payne, Christopher J Kemp
Toxicologic Pathology|July 10, 2003
p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screeningShannon R Payne, Christopher J Kemp
Cancer Cell|June 28, 2002
Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant miceJeannette Philipp-Staheli, Kyung-Hoon Kim, Shannon R Payne, et al.
Molecular and Cellular Biology|October 24, 2007
p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instabilityShannon R Payne, Shulin Zhang, Karen Tsuchiya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2013
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of centerShannon R Payne, Timothy R Church, Michael Wandell, et al.
The Prostate|May 22, 2009
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detectionShannon R Payne, Jurgen Serth, Martin Schostak, et al.
Gut|February 15, 2013
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancerTimothy Robert Church, Michael Wandell, Catherine Lofton-Day, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Epigenomics|November 30, 2011
From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in bloodShannon R Payne
Carcinogenesis|September 10, 2005
Tumor suppressor geneticsShannon R Payne, Christopher J Kemp
Toxicologic Pathology|July 10, 2003
p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screeningShannon R Payne, Christopher J Kemp
Cancer Cell|June 28, 2002
Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant miceJeannette Philipp-Staheli, Kyung-Hoon Kim, Shannon R Payne, et al.
Molecular and Cellular Biology|October 24, 2007
p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instabilityShannon R Payne, Shulin Zhang, Karen Tsuchiya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2013
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of centerShannon R Payne, Timothy R Church, Michael Wandell, et al.
The Prostate|May 22, 2009
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detectionShannon R Payne, Jurgen Serth, Martin Schostak, et al.
Gut|February 15, 2013
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancerTimothy Robert Church, Michael Wandell, Catherine Lofton-Day, et al.
Pageof 1